Vaishali Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Vaishali Pharma has a total shareholder equity of ₹428.4M and total debt of ₹126.1M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are ₹799.6M and ₹371.2M respectively. Vaishali Pharma's EBIT is ₹6.3M making its interest coverage ratio 0.4. It has cash and short-term investments of ₹15.8M.
Key information
29.4%
Debt to equity ratio
₹126.10m
Debt
| Interest coverage ratio | 0.4x |
| Cash | ₹15.78m |
| Equity | ₹428.39m |
| Total liabilities | ₹371.16m |
| Total assets | ₹799.56m |
Recent financial health updates
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Recent updates
Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23Financial Position Analysis
Short Term Liabilities: VAISHALI's short term assets (₹745.2M) exceed its short term liabilities (₹330.8M).
Long Term Liabilities: VAISHALI's short term assets (₹745.2M) exceed its long term liabilities (₹40.3M).
Debt to Equity History and Analysis
Debt Level: VAISHALI's net debt to equity ratio (25.8%) is considered satisfactory.
Reducing Debt: VAISHALI's debt to equity ratio has reduced from 79.8% to 29.4% over the past 5 years.
Debt Coverage: VAISHALI's debt is not well covered by operating cash flow (6.4%).
Interest Coverage: VAISHALI's interest payments on its debt are not well covered by EBIT (0.4x coverage).